210962-44-0

Basic information

• Product Name: tert-butyl 4-(4-(ethoxycarbonyl)phenoxy)piperidine-1-carboxylate
• Synonyms: tert-butyl 4-(4-(ethoxycarbonyl)phenoxy)piperidine-1-carboxylate
• CAS NO: 210962-44-0
• Molecular Weight: 349.427
• Mol File: 210962-44-0.mol
• Article Data: 10

Chemical Properties

• Boiling Point: 459.0±35.0 °C(Predicted)
• Density: 1.132±0.06 g/cm3(Predicted)
• CAS DataBase Reference: tert-butyl 4-(4-(ethoxycarbonyl)phenoxy)piperidine-1-carboxylate(CAS DataBase Reference)
• NIST Chemistry Reference: tert-butyl 4-(4-(ethoxycarbonyl)phenoxy)piperidine-1-carboxylate(210962-44-0)
• EPA Substance Registry System: tert-butyl 4-(4-(ethoxycarbonyl)phenoxy)piperidine-1-carboxylate(210962-44-0)

Safety Data

• Hazardous Substances Data: 210962-44-0(Hazardous Substances Data)

Upstream product

• 120-47-8 Ethyl 4-hydroxybenzoate 
• 109384-19-2 t-butyl 4-hydroxy piperidine-1-carboxylate 
• 1972-28-7 diethylazodicarboxylate 

Downstream Products

• 460365-21-3 C₁₄H₁₉NO₃ 
• 950649-16-8 4-(4-carboxyethylphenyloxy)-piperidine-1-carboxylic acid 2,4-dichloro-benzylamide 
• 321337-38-6 tert-butyl 4-(4-(hydroxymethyl)phenoxy)piperidine-1-carboxylate 
• 950649-15-7 4-(4-carboxyethylphenyloxy)-1-piperidine hydrochloride 
• 538335-94-3 methyl 2-acetamido-3-[2-(2R)-2-[4-(1-tert-butoxycarbonylpiperidyl-4-oxy)benzoylamino-3-benzyloxycarbonylpropoxy]-4-cyanophenyl]acrylate 
• 538335-97-6 methyl 2-acetamido-3-[4-amidino-2-[(2R)-3-ethoxycarbonyl-2-[4-(piperidyl-4-oxy)benzoylamino]propoxy]phenyl]acrylate 
• 538335-90-9 methyl 2-acetamido-3-[2-[2-[4-(1-tert-butoxycarbonyl-4-piperidyloxy)benzoylamino]ethoxy]-4-cyanophenyl]acrylate 
• 538336-04-8 ethyl 3-[2-[2-[(1-acetimidoyl-4-piperidyloxy)benzoylamino]ethoxy]-4-amidinophenyl]acrylate 
• 252261-63-5 ethyl 3-[2-[2-[(1-acetimidoyl-4-piperidyloxy)benzoylamino]ethoxy]-4-amidinophenyl]propionate 
• 538336-01-5 ethyl 3-[2-[2-[4-(1-tert-butoxycarbonyl-4-piperidyloxy)benzoylamino]ethoxy]-4-cyanophenyl]acrylate 
• 1026523-08-9 ethyl 3-[2-[2-[4-(4-piperidyloxy)benzoylamino]ethoxy]-4-amidinophenyl]acrylate 
• 210962-73-5 N-[2-(3-cyanophenoxy)ethyl]-4-(1-tert-butoxycarbonyl-4-piperidyloxy)benzamide 

Relevant articles and documents

DIAZANAPHTHALEN-3-YL CARBOXAMIDES AND PREPARATION AND USE THEREOF

Diazanaphthalene compounds for treating various diseases and pathologies are disclosed. More particularly, the present disclosure concerns the use of a diazanaphthalene compound or analogs thereof, in the treatment of disorders characterized by the activa

ISOQUINOLIN-3-YL CARBOXAMIDES AND PREPARATION AND USE THEREOF

Isoquinoline compounds for treating various diseases and pathologies are disclosed. More particularly, the present invention concerns the use of an isoquinoline compound or analogs thereof, in the treatment of disorders characterized by the activation of Wnt pathway signaling (e.g., cancer, abnormal cellular proliferation, angiogenesis, fibrotic disorders, bone or cartilage diseases, and osteoarthritis), the modulation of cellular events mediated by Wnt pathway signaling, as well as genetic diseases and neurological conditions/disorders/diseases due to mutations or dysregulation of the Wnt pathway and/or of one or more of Wnt signaling components. Also provided are methods for treating Wnt-related disease states.

QUINAZOLINE DERIVATIVE

This invention provides a compound or its pharmaceutically-acceptable salt of formula (I) wherein R 1 represents a lower alkyl group et al; R 2 and R 3 are same and different and represents hydrogen atm et al; R 4 represents the substituent of the formula (II) et al; X 1 represents NH, O or S; Y represents N or C; Ar is a divalent substituent derived from aryl et al, by removing two hydrogen atoms therefrom; the ring A represents a 5- or 6-membered heteroaryl group; this compounds has a histamine-H3 receptor antagonistic effect or a histamine-H3 receptor inverse-agonistic effect and is useful for preventive or remedy of metabolic system diseases, circulatory system diseases or nervous system diseases.